106 related articles for article (PubMed ID: 29265076)
1. [Tissue collagenase MMP-14 and endogenous regulators of its activity in the corpus uteri in squamous cell carcinoma of the cervix].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2017; 79(6):36-42. PubMed ID: 29265076
[TBL] [Abstract][Full Text] [Related]
2. [Gelatinases A and B and their endogenous regulators in the corpus uteri in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2018; 80(6):22-28. PubMed ID: 30585589
[TBL] [Abstract][Full Text] [Related]
3. [Membrane type 1 matrix metalloproteinase (MT1-MMP) and the regulators of its activity as invasive factors in squamous cell cervical carcinomas].
Timoshenko OS; Gureeva TA; Kugaevskaia EV; Solov'eva NI
Biomed Khim; 2014; 60(6):683-8. PubMed ID: 25552509
[TBL] [Abstract][Full Text] [Related]
4. [Key enzymes of degradation and angiogenesis as a factors of tumor progression in squamous cell carcinoma of the cervix].
Solov'eva NI; Timoshenko OS; Kugaevskaia EV; Andreeva IuIu; Zavalishina LE
Bioorg Khim; 2014; 40(6):743-51. PubMed ID: 25895371
[TBL] [Abstract][Full Text] [Related]
5. [Matrix metalloproteinases 2 and 9, their endogenous regulators, and angiotensin-converting enzyme in cervical squamous cell carcinoma].
Timoshenko OS; Kugaevskaya EV; Gureeva TA; Zavalishina LE; Andreeva YY; Solovуeva NI
Arkh Patol; 2015; 77(5):31-35. PubMed ID: 26978018
[TBL] [Abstract][Full Text] [Related]
6. [Interstitial collagenase and their endogenous regulators in squamous cell cervical carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Solovyeva NI
Biomed Khim; 2017 Nov; 63(6):513-519. PubMed ID: 29251612
[TBL] [Abstract][Full Text] [Related]
7. [The expression of EMMPRIN and the matrix metalloproteinase MMP-1 in the cervix uteri and corpus uteri in cervical squamous cell carcinoma].
Timoshenko OS; Gureeva TA; Kugaevskaya EV; Zavalishina LE; Andreeva YY; Solovyeva NI
Arkh Patol; 2019; 81(6):34-40. PubMed ID: 31851190
[TBL] [Abstract][Full Text] [Related]
8. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].
Zhou CY; Yao JF; Chen XD
Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097
[TBL] [Abstract][Full Text] [Related]
9. Tumoral and stromal expression of MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2, and VEGF-A in cervical cancer patient survival: a competing risk analysis.
Azevedo Martins JM; Rabelo-Santos SH; do Amaral Westin MC; Zeferino LC
BMC Cancer; 2020 Jul; 20(1):660. PubMed ID: 32669083
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
[TBL] [Abstract][Full Text] [Related]
11. [Matrix metalloproteinases and their endogenous regulators in squamous cervical carcinoma (review of the own data)].
Solovуeva NI; Timoshenko OS; Gureeva TA; Kugaevskaya EV
Biomed Khim; 2015; 61(6):694-704. PubMed ID: 26716740
[TBL] [Abstract][Full Text] [Related]
12. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
Ottino P; He J; Axelrad TW; Bazan HE
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):487-96. PubMed ID: 15671273
[TBL] [Abstract][Full Text] [Related]
13. [Interstitial collagenase, gelatinases A and B and their endogenous inhibitors in squamous cell cervical carcinomas].
Ryzhakova OS; Zavalishina LÉ; Andreeva IuIu; Solov'eva NI
Biomed Khim; 2013; 59(1):55-64. PubMed ID: 23650722
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
16. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
17. Significant relation of tissue inhibitor of matrix metalloproteinase-2 and its combination with matrix metalloproteinase-2 to survival of patients with cancer of uterine cervix.
Wang PH; Ko JL; Yang SF; Tsai HT; Tee YT; Han CP; Lin LY; Chen SC; Shih YT
Reprod Sci; 2011 Aug; 18(8):798-808. PubMed ID: 21422052
[TBL] [Abstract][Full Text] [Related]
18. Interstitial collagenase MMP-1 and EMMPRIN in cell lines and in clinical specimens of cervical squamous cell carcinoma.
Solovyeva NI; Timoshenko OS; Kugaevskaya EV; Gureeva TA
Mol Biol Rep; 2021 Oct; 48(10):6879-6886. PubMed ID: 34495460
[TBL] [Abstract][Full Text] [Related]
19. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines.
Iwasaki M; Nishikawa A; Fujimoto T; Akutagawa N; Manase K; Endo T; Yoshida K; Maekawa R; Yoshioka T; Kudo R
Gynecol Oncol; 2002 Apr; 85(1):103-7. PubMed ID: 11925127
[TBL] [Abstract][Full Text] [Related]
20. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.
Lenhart JA; Ryan PL; Ohleth KM; Palmer SS; Bagnell CA
Endocrinology; 2002 Jan; 143(1):91-8. PubMed ID: 11751597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]